Jung Tae Lee

Title: Innovations by Jung Tae Lee in Liquid Formulations

Introduction

Jung Tae Lee is an accomplished inventor based in Yuseong-gu, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of liquid formulations for fusion proteins. His innovative work focuses on enhancing the stability and usability of therapeutic proteins.

Latest Patents

Jung Tae Lee holds a patent for a liquid formulation of a fusion protein comprising TNFR and an Fc region. This invention relates to a formulation that includes a TNFR-Fc fusion protein and a stabilizer. The stabilizer consists of amino acids such as proline and histidine, along with a buffer solution and an isotonic agent containing sodium chloride (NaCl) and sucrose. The formulation provides excellent storage stability, allowing for long-term storage of TNFR-Fc fusion protein (etanercept) without the need for specific storage conditions. This economical formulation is advantageous for applications where the treatment of TNFR-Fc fusion protein is beneficial.

Career Highlights

Jung Tae Lee is associated with Ares Trading S.A., where he continues to advance his research and development efforts. His work has been pivotal in creating formulations that are not only effective but also cost-efficient, making them suitable for widespread use in therapeutic applications.

Collaborations

Jung Tae Lee has collaborated with notable colleagues, including In Hyuk Kim and Jae Keun Yu. These partnerships have contributed to the successful development and refinement of his innovative formulations.

Conclusion

Jung Tae Lee's contributions to the field of biopharmaceuticals, particularly through his patent on liquid formulations, demonstrate his commitment to improving therapeutic options. His work is poised to have a lasting impact on the treatment of various medical conditions.